+620.0%
P vs GSK
+107.3%
+512.7%
-69.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.0% | -0.1% | -3.9% | -4.0% |
| 7D | +0.8% | -1.3% | +2.1% | +1.1% |
| 30D | -16.4% | +2.7% | -19.1% | -16.9% |
| 3M | -12.3% | +2.7% | -15.0% | -13.0% |
| 6M | +27.7% | +3.3% | +24.4% | +25.4% |
| YTD | +54.7% | +6.5% | +48.3% | +49.8% |
| 1Y | +22.6% | +10.7% | +11.9% | +17.1% |
| 3Y | +186.7% | +64.4% | +122.4% | +130.6% |
| 5Y | +268.6% | +46.7% | +221.9% | +203.6% |
| 10Y | +620.0% | +109.4% | +510.6% | +382.0% |
| All | +620.0% | +107.3% | +512.7% | +382.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling